Warren Cowell

1.8k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Warren Cowell is a scholar working on Economics and Econometrics, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Warren Cowell has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 6 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Warren Cowell's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Warren Cowell is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Warren Cowell collaborates with scholars based in United Kingdom, United States and Switzerland. Warren Cowell's co-authors include Gregory Y.H. Lip, Sharon A. Welner, Nick Newton, Joyce A. Cramer, Niall Lynch, Mel Walker, Dyfrig Hughes, Tamás Koncz, Anne-Françoise Gaudin and Femida Gwadry‐Sridhar and has published in prestigious journals such as The American Journal of Medicine, The American Journal of Cardiology and Thrombosis and Haemostasis.

In The Last Decade

Warren Cowell

21 papers receiving 1.2k citations

Hit Papers

Underuse of Oral Anticoagulants in Atrial Fibrillation: A... 2010 2026 2015 2020 2010 200 400 600

Peers

Warren Cowell
Allison Keshishian United States
Ulf Maywald Germany
S. Mueller Germany
Kamil F. Faridi United States
Irene D. Bezemer Netherlands
Allison Keshishian United States
Warren Cowell
Citations per year, relative to Warren Cowell Warren Cowell (= 1×) peers Allison Keshishian

Countries citing papers authored by Warren Cowell

Since Specialization
Citations

This map shows the geographic impact of Warren Cowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren Cowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren Cowell more than expected).

Fields of papers citing papers by Warren Cowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren Cowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren Cowell. The network helps show where Warren Cowell may publish in the future.

Co-authorship network of co-authors of Warren Cowell

This figure shows the co-authorship network connecting the top 25 collaborators of Warren Cowell. A scholar is included among the top collaborators of Warren Cowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren Cowell. Warren Cowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pouwels, Xavier, Chris Sampson, Renée J.G. Arnold, et al.. (2022). Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey. Value in Health. 25(4). 473–479. 11 indexed citations
2.
Bullement, Ash, et al.. (2019). “Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval. Value in Health. 23(2). 191–199. 2 indexed citations
3.
Gutiérrez, Laura, et al.. (2015). Principles for consistent value assessment and sustainable funding of orphan drugs in Europe. Orphanet Journal of Rare Diseases. 10(1). 53–53. 28 indexed citations
5.
Hiligsmann, Mickaël, Maribel Salas, Dyfrig Hughes, et al.. (2013). Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group. Osteoporosis International. 24(12). 2907–2918. 57 indexed citations
6.
Hiligsmann, Mickaël, Maribel Salas, Dyfrig Hughes, et al.. (2011). Most Effective Interventions to Improve Patient Compliance with Osteoporosis Medications. Osteoporosis International. 22. 1 indexed citations
7.
Welner, Sharon A., et al.. (2011). Characterization of the Proportion of Untreated and Antiplatelet Therapy Treated Patients With Atrial Fibrillation. The American Journal of Cardiology. 108(1). 151–161. 27 indexed citations
8.
Hiligsmann, Mickaël, Maribel Salas, Dyfrig Hughes, et al.. (2011). PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS. Value in Health. 14(3). A130–A130. 2 indexed citations
9.
Cowell, Warren, et al.. (2011). Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients. Thrombosis and Haemostasis. 106(7). 34–44. 34 indexed citations
10.
Newton, Nick, et al.. (2010). Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review. The American Journal of Medicine. 123(7). 638–645.e4. 687 indexed citations breakdown →
11.
Filippi, Alessandro, Marianna Alacqua, Warren Cowell, et al.. (2010). A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. Thrombosis and Haemostasis. 103(5). 968–975. 39 indexed citations
12.
Adachi, Jonathan D., et al.. (2007). The association between compliance and persistence with bisphosphonate therapy and fracture risk: A review. BMC Musculoskeletal Disorders. 8(1). 97–97. 38 indexed citations
13.
Briggs, Andrew, et al.. (2007). Recombinant Erythropoietin for Chemotherapy-Related Anaemia. PharmacoEconomics. 25(3). 223–237. 33 indexed citations
14.
Hughes, Dyfrig, Warren Cowell, Tamás Koncz, & Joyce A. Cramer. (2007). Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations. Value in Health. 10(6). 498–509. 86 indexed citations
15.
Cowell, Warren, et al.. (2007). PCN25 PHARMACOECONOMIC EVALUATION OF CAPECITABINE (XELODA) FOR GASTRIC CANCER IN THE UNITED KINGDOM. Value in Health. 10(6). A330–A330.
16.
Walker, Mel, et al.. (2006). The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Current Medical Research and Opinion. 22(7). 1249–1256. 54 indexed citations
17.
Cramer, Joyce A., Niall Lynch, Anne-Françoise Gaudin, Mel Walker, & Warren Cowell. (2006). The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: A comparison of studies in the United States, the United Kingdom, and France. Clinical Therapeutics. 28(10). 1686–1694. 89 indexed citations
18.
Agrawal, Samir, Neville Davidson, Mel Walker, et al.. (2006). Assessing the total costs of blood delivery to hospital oncology and haematology patients. Current Medical Research and Opinion. 22(10). 1903–1909. 24 indexed citations
20.
Briggs, Andrew, et al.. (2004). PCN34 UTILITY ASSOCIATED WITH SEVERITY OF CANCER-RELATED ANAEMIA (CRA): A SOCIETAL VALUATION. Value in Health. 7(6). 680–680. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026